The FDA warned the nation about the growing vulnerability of the medical device supply chain and its effects on public health, particularly among pediatric patients, in a Jan. 16 news release.
Shares of Cardinal Health (CAH) have been strong performers lately, with the stock up 8.6% over the past month. The stock hit a new 52-week high of $127.08 in the previous session. Cardinal Health has ...
Leerink Partners analyst Michael Cherny has maintained their bullish stance on CAH stock, giving a Buy rating on January 15.Stay Ahead of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback